探索病毒进入的秘密:第一个携带β乳糖酶的呼吸道同胞病毒
Marcio De Ávila-Arias1, Jose Luis Villarreal-Camacho2, Christian Cadena-Cruz2
1Departamento de Medicina, División Ciencias de la Salud, Universidad del Norte, Barranquilla, Colombia.
Frontiers in microbiology
|March 8, 2024
概括
这项研究设计了一种新型呼吸道同胞细胞病毒 (RSV) 变种,具有P-BlaM仿真体,以研究病毒进入. 研究人员确定奎尔塞丁和乌利克塞提尼布是RSV感染的潜在抑制剂.
科学领域:
- 病毒学 病毒学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 呼吸道共囊病毒 (RSV) 构成严重的健康风险,特别是在幼儿中.
- 了解RSV进入机制对于开发有效的抗病毒疗法至关重要.
- 这项研究引入了一种新型RSV变异,该变异由与RSV-P光蛋白融合的β-乳酸酶 (BlaM) 工程.
研究的目的:
- 开发一种用于剖析RSV病毒进入动态的多功能工具.
- 描述工程P-BlaM金像的结构和功能.
- 为了确定RSV感染的潜在治疗点和抗病毒药物.
主要方法:
- 使用AlphaFold2.2.进行P-BlaM仿真体的三级结构建模.
- 通过流细胞计量进行功能性评估,以量化β-乳酸酶活性和GFP表达.
- 西方斑点分析证实了病毒体中的P-BlaM完整性.
主要成果:
- 在结构上,P-BlaM仿真体与RSV-P和BlaM都有相似之处.
- 再组合病毒表现出显著的β-乳糖酶活性,证实了P-BlaM的结合.
- 奎尔塞丁通过影响病毒融合来抑制病毒的进入,而Ulixertinib (ERK-1/2抑制剂) 则减少了病毒的进入,这涉及到ERK-1/2信号传输.
结论:
- 工程 RSV-P-BlaM 嵌合体作为一个有价值的工具来研究 RSV 进入机制.
- 结构和功能分析揭示了RSV的潜在治疗点.
- 奎尔塞丁和乌利克塞蒂尼布作为向性抗病毒药物表现有前途,并确定了干扰的特定阶段.
相关概念视频
Leaky Scanning
4.5K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
4.5K
Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Pneumonia II: Pathophysiology
4.7K
The pathophysiology of pneumonia involves the following steps:
4.7K
Bacterial Translocation and Protein Secretion
1.2K
Bacterial protein secretion involves translocation systems to ensure proteins reach their designated locations, including the plasma membrane, periplasm, outer membrane, or the external environment. These translocation systems are vital for bacterial physiology, supporting processes like membrane assembly, enzymatic activity in the periplasm, and interactions with the external environment. The division of labor between Sec and Tat pathways ensures efficiency in handling proteins with diverse...
1.2K
Atypical Pneumonia
88
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
88
Mechanism of Antibiotic Resistance in MRSA
245
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
245


